Quick Historical Income Statement

QUICKHEAL

293.05 15.30 4.96%

Historical analysis of Quick Heal income statement accounts such as Gross Profit of 2 B, Other Operating Expenses of 2.4 B, Operating Income of 46.3 M or Ebit of 224.1 M can show how well Quick Heal Technologies performed in making a profits. Evaluating Quick Heal income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Quick Heal's future profits or losses.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Quick Heal Technologies latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Quick Heal Technologies is a good buy for the upcoming year.

Net Income Gross Profit

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quick Heal Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

About Quick Income Statement Analysis

Quick Heal Technologies Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Quick Heal shareholders. The income statement also shows Quick investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Quick Heal Income Statement Chart

At present, Quick Heal's Selling And Marketing Expenses is projected to decrease significantly based on the last few years of reporting. The current year's Gross Profit is expected to grow to about 2 B, whereas Total Revenue is forecasted to decline to about 3.2 B.

Selling General Administrative Selling And Marketing Expenses Total Revenue Gross Profit

Total Revenue

Total revenue comprises all receipts Quick Heal Technologies generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Quick Heal Technologies minus its cost of goods sold. It is profit before Quick Heal operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Most accounts from Quick Heal's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Quick Heal Technologies current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quick Heal Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in industry.

	2022	2023	2024	2025 (projected)
Gross Profit	2.7B	1.2B	1.1B	2.0B
Total Revenue	2.8B	2.9B	3.4B	3.2B

Gross Profit Total Revenue

Quick Heal income statement Correlations

	Depreciation And Amortization	Selling General Administrative	Selling And Marketing Expenses	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Tax Provision	Interest Income	Net Interest Income	Reconciled Depreciation	Research Development
Depreciation And Amortization		-0.22	-0.02	0.74	0.64	0.52	-0.04	-0.13	0.07	0.0	0.7	0.1	-0.66	0.06	0.17	0.27	0.24	0.57	-0.09	0.06	-0.16
Selling General Administrative	-0.22		-0.48	0.11	-0.46	0.55	-0.73	-0.66	-0.69	0.43	0.14	-0.74	0.24	-0.71	-0.77	-0.67	-0.78	-0.54	-0.62	-0.71	0.73
Selling And Marketing Expenses	-0.02	-0.48		-0.2	0.33	-0.27	0.29	0.18	0.18	-0.41	0.11	0.14	-0.43	0.08	0.26	0.05	0.3	-0.08	0.63	0.61	-0.46
Total Revenue	0.74	0.11	-0.2		0.24	0.82	-0.27	-0.24	-0.11	0.49	0.5	-0.14	-0.35	-0.11	-0.19	0.12	-0.13	0.09	-0.57	-0.48	0.28
Gross Profit	0.64	-0.46	0.33	0.24		-0.06	0.45	0.37	0.51	-0.68	0.68	0.52	-0.73	0.46	0.6	0.56	0.64	0.69	0.32	0.49	-0.64
Other Operating Expenses	0.52	0.55	-0.27	0.82	-0.06		-0.71	-0.69	-0.59	0.58	0.55	-0.61	-0.26	-0.59	-0.62	-0.39	-0.56	-0.21	-0.71	-0.71	0.65
Operating Income	-0.04	-0.73	0.29	-0.27	0.45	-0.71		0.98	0.98	-0.63	-0.34	0.97	-0.16	0.96	0.95	0.89	0.94	0.55	0.67	0.73	-0.88
Ebit	-0.13	-0.66	0.18	-0.24	0.37	-0.69	0.98		0.98	-0.55	-0.41	0.95	-0.07	0.96	0.89	0.89	0.87	0.45	0.55	0.6	-0.8
Ebitda	0.07	-0.69	0.18	-0.11	0.51	-0.59	0.98	0.98		-0.58	-0.26	0.98	-0.23	0.98	0.93	0.95	0.93	0.58	0.55	0.63	-0.84
Cost Of Revenue	0.0	0.43	-0.41	0.49	-0.68	0.58	-0.63	-0.55	-0.58		-0.19	-0.6	0.46	-0.53	-0.71	-0.47	-0.7	-0.58	-0.71	-0.77	0.76
Total Operating Expenses	0.7	0.14	0.11	0.5	0.68	0.55	-0.34	-0.41	-0.26	-0.19		-0.25	-0.63	-0.29	-0.14	-0.13	-0.08	0.28	-0.21	-0.09	0.06
Income Before Tax	0.1	-0.74	0.14	-0.14	0.52	-0.61	0.97	0.95	0.98	-0.6	-0.25		-0.21	0.99	0.97	0.96	0.95	0.68	0.55	0.65	-0.85
Total Other Income Expense Net	-0.66	0.24	-0.43	-0.35	-0.73	-0.26	-0.16	-0.07	-0.23	0.46	-0.63	-0.21		-0.15	-0.31	-0.27	-0.37	-0.39	-0.26	-0.35	0.48
Net Income	0.06	-0.71	0.08	-0.11	0.46	-0.59	0.96	0.96	0.98	-0.53	-0.29	0.99	-0.15		0.92	0.97	0.91	0.64	0.46	0.56	-0.8
Income Tax Expense	0.17	-0.77	0.26	-0.19	0.6	-0.62	0.95	0.89	0.93	-0.71	-0.14	0.97	-0.31	0.92		0.89	0.99	0.74	0.69	0.79	-0.89
Net Income From Continuing Ops	0.27	-0.67	0.05	0.12	0.56	-0.39	0.89	0.89	0.95	-0.47	-0.13	0.96	-0.27	0.97	0.89		0.89	0.7	0.35	0.47	-0.77
Tax Provision	0.24	-0.78	0.3	-0.13	0.64	-0.56	0.94	0.87	0.93	-0.7	-0.08	0.95	-0.37	0.91	0.99	0.89		0.76	0.68	0.79	-0.89
Interest Income	0.57	-0.54	-0.08	0.09	0.69	-0.21	0.55	0.45	0.58	-0.58	0.28	0.68	-0.39	0.64	0.74	0.7	0.76		0.37	0.51	-0.6
Net Interest Income	-0.09	-0.62	0.63	-0.57	0.32	-0.71	0.67	0.55	0.55	-0.71	-0.21	0.55	-0.26	0.46	0.69	0.35	0.68	0.37		0.95	-0.75
Reconciled Depreciation	0.06	-0.71	0.61	-0.48	0.49	-0.71	0.73	0.6	0.63	-0.77	-0.09	0.65	-0.35	0.56	0.79	0.47	0.79	0.51	0.95		-0.85
Research Development	-0.16	0.73	-0.46	0.28	-0.64	0.65	-0.88	-0.8	-0.84	0.76	0.06	-0.85	0.48	-0.8	-0.89	-0.77	-0.89	-0.6	-0.75	-0.85

Click cells to compare fundamentals

Quick Heal Account Relationship Matchups

Quick Heal income statement Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Depreciation And Amortization	194.9M	170.8M	147.5M	110.9M	127.5M	205.9M
Selling General Administrative	101.4M	156.1M	271.4M	205.3M	236.1M	140.5M
Selling And Marketing Expenses	233.1M	282.4M	347.8M	187.5M	168.8M	294.3M
Total Revenue	3.3B	3.4B	2.8B	2.9B	3.4B	3.2B
Gross Profit	3.1B	1.9B	2.7B	1.2B	1.1B	2.0B
Other Operating Expenses	2.1B	2.5B	2.9B	2.8B	3.3B	2.4B
Operating Income	1.2B	904.2M	(98.2M)	54.2M	48.8M	46.3M
Ebit	1.5B	1.1B	80.2M	262.1M	235.9M	224.1M
Ebitda	1.7B	1.3B	227.7M	373M	335.7M	318.9M
Cost Of Revenue	191.1M	1.5B	93.3M	1.8B	2.0B	2.1B
Total Operating Expenses	1.9B	1.0B	2.8B	1.2B	1.3B	1.9B
Income Before Tax	1.5B	1.1B	80.2M	262.1M	235.9M	224.1M
Total Other Income Expense Net	(297.1M)	(494M)	(672.7M)	207.9M	239.1M	251.0M
Net Income	1.1B	831.9M	64M	242.4M	218.2M	207.3M
Income Tax Expense	391.6M	254.9M	16.2M	19.7M	17.7M	16.8M
Interest Expense	290.9M	307.6M	221.3M	1.3M	1.5M	1.4M
Net Income From Continuing Ops	1.1B	831.9M	64M	242.4M	218.2M	207.3M
Net Income Applicable To Common Shares	744.1M	1.1B	831.9M	64M	73.6M	69.9M
Tax Provision	391.6M	254.9M	16.2M	19.7M	17.7M	16.8M
Interest Income	177.8M	29M	17.8M	12.9M	11.6M	11.0M
Net Interest Income	71.3M	29M	17.8M	(1.3M)	(1.2M)	(1.1M)
Reconciled Depreciation	194.9M	173.8M	159.9M	126M	113.4M	157.3M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Other Information on Investing in Quick Stock

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Quick Historical Income Statement

About Quick Income Statement Analysis

Quick Heal Income Statement Chart

Total Revenue

Gross Profit

Quick Heal income statement Correlations

Quick Heal Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Quick Heal income statement Accounts

Also Currently Popular

Other Information on Investing in Quick Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Net Income	+ 0.99	Income Before Tax
Tax Provision	+ 0.99	Income Tax Expense
Ebit	+ 0.98	Operating Income
Ebitda	+ 0.98	Operating Income
Ebitda	+ 0.98	Ebit
Income Before Tax	+ 0.98	Ebitda

Research Development	- 0.89	Tax Provision
Research Development	- 0.89	Income Tax Expense
Research Development	- 0.88	Operating Income
Research Development	- 0.85	Reconciled Depreciation
Research Development	- 0.85	Income Before Tax
Research Development	- 0.84	Ebitda